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Introduction: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is
increasingly recognized as an important pathogen. Panton–Valentine leukocidin (PVL)-producing
CA-MRSA constitutes a public health concern because it can be responsible for severe,
progressive necrotizing skin, soft-tissue and pulmonary infections.
Case presentation: We describe a case of recurrent transmission of PVL-producing ST5,
staphylococcal cassette chromosome mec type IV MRSA (paediatric clone) from an
asymptomatic nasal carrier to his family causing severe skin and soft-tissue infections in the
mother and children. Nasal application of mupirocin in the carrier was successful for prevention of
new infections.
Conclusion: Recurrent skin infections are often not taken into account but may represent a
serious threat if caused by a PVL-producing MRSA strain. Family members of MRSA carriers are
in danger of transmission. Characteristics of currently circulating CA-MRSA strains require closer
surveillance. Identification and decolonization of carriers is important to reduce the risk of spread
into the community.
Keywords: intrafamilial spread; nasal carrier; PVL-positive CA-MRSA; SSCmecIV; ST5; skin
infections.
Introduction
Originally isolated from hospitalized patients in the 1960s
and still endemic in many hospitals worldwide, methicillin-
resistant Staphylococcus aureus (MRSA) has been increas-
ingly observed in community settings, predominantly
affecting healthy individuals without connections to health-
care facilities (Prosperi et al., 2013). Community-acquired
(CA)-MRSA strains are distinguishable from hospital-
acquired (HA)-MRSA strains by virtue of the carriage of
certain staphylococcal cassette chromosome mec (SCCmec)
types, which are usually types IV and V (Chambers & Deleo,
2009), the production of the bicomponent cytotoxin
Panton–Valentine leukocidin (PLV) and by assignment to
distinct spa types and clonal complexes (CCs) and sequence
types (STs) (Cookson et al., 2007). Previous studies have
shown that, in contrast to the situation in the USA where
epidemic CA-MRSA clones ST1-IV (USA400) and ST8-IV
(USA300) prevail, a larger genetic diversity is observed in
Europe (Rolo et al., 2012), with ST80-IV being the most
common CA-MRSA (Otter & French, 2010). Here, we
describe the intrafamilial transmission of a PVL-positive
CA-MRSA strain belonging to the so-called paediatric clone,
which is a clone originating from the hospital environment
and hitherto, in contrast to previous reports (Liassine et al.,
2004), not described as a clone typical for CA-MRSA in
Switzerland. Community-acquired skin infections are rarely
characterized, and hence the prevalence of CA-MRSA in
Switzerland may be underestimated. A picture of the local
epidemiology of CA-MRSA and the detection of carriers is
necessary for successful transmission control.
Case report
A 41-year-old female presented to her general practitioner
with a 4-day history of an enlarging painful lesion on her
Abbreviations: CA, community acquired; CC, clonal complex; HA,
hospital acquired; MRSA, methicillin-resistant Staphylococcus aureus;
PVL, Panton–Valentine leukocidin; SSCmec, staphylococcal cassette
chromosome mec; ST, sequence type
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left arm that she attributed to a mosquito bite. Her
personal history was unremarkable, but she reported her 4-
year-old son as having had an untreated lesion located on
his upper lip and her 1-year-old daughter as having
received antibiotic therapy for an MRSA-related gluteal
abscess, which had been diagnosed and treated at a
children’s hospital several weeks prior to consultation. The
patient was diagnosed with a volar abscess including
erysipelas extending from the wrist to the elbow. Incision
and drainage was performed and a swab was taken for
microbiological analysis. Culture of the pus yielded MRSA.
Oral therapy with cotrimoxazole (800 mg sulfamethox-
azole/160 mg trimethoprim, twice daily for 14 days) was
initiated. Quarantine measures were recommended regard-
ing exposure of the wound to immunosuppressed persons,
persons with open wounds and pregnant women. Over the
next 3 days, the wound was inspected and rinsed daily, and
was disinfected with iodine tincture (11 mg ml21), while
therapy with cotrimoxazole continued. Following an initial
amelioration, the accumulation of pus necessitated
renewed and extensive incision and drainage, to the extent
of partial exposure of the flexor tendon. Four days after
diagnosis, the patient’s son presented to the same general
practitioner with a painful lesion on his right thigh.
Therapy with cotrimoxazole (200 mg sulfamethoxazole/
40 mg trimethoprim, twice daily for 5 days) was initi-
alized. Culture of pus taken from the lesion revealed
MRSA. Over the next days, treatment was carried out as
described above, and after 6 days, both mother and son
presented with granulating wounds without further signs
of irritation. Seven days later, the son presented again with
two painful lesions on his right knee that he attributed to
mosquito bites. Culture of the pus yielded MRSA.
Treatment as described above was administered. To
elucidate a possible reservoir within this family, nasal
swabs were obtained from both nares of each family
member. No pets were present in this family. Culture of
the swabs revealed MRSA from both nares of the 44-year-
old father who had never presented with MRSA infections,
while the samples obtained from the mother, son and
daughter yielded negative results. Decolonization therapy
with nasal ointment containing 20 mg mupirocin g21 was
initiated and maintained for 5 days. Two days after
termination of antibiotic treatment, nasal swabs yielded
negative MRSA results.
For MRSA detection, samples were subjected to a two-step
enrichment procedure in Mueller–Hinton broth supple-
mented with 6.5 % NaCl (24 h at 37 uC) and brain–heart
infusion broth with 75 mg aztreonam l21 and 5 mg
cefoxitin l21 (24 h at 37 uC), and plated onto Brilliance
MRSA Agar (Oxoid) and incubated for 24 h at 37 uC.
Four selected isolates were further characterized by
SCCmec typing (Boye et al., 2007), determination of
multilocus sequence typing (Enright et al., 2000) and spa
typing (Aires-de-Sousa et al., 2006). An S. aureus
Genotyping kit (Alere Technologies) was used to detect
the presence or absence of 333 genes and their allelic
variants including species markers and virulence genes, as
well as genes conferring resistance to antimicrobial agents.
Microarray results allowed the confirmation of strain
assignment to CCs (Monecke et al., 2008). Susceptibility to
penicillin, cefoxitin, ciprofloxacin, clindamycin, erythro-
mycin, gentamicin, rifampicin, sulfamethoxazole/tri-
methoprim, tetracycline and vancomycin was tested
using antibiotic disks (Becton Dickinson) according to
the guidelines of the Clinical and Laboratory Standards
Institute (CLSI, 2013). Susceptibility to daptomycin and
linezolid was tested using Etest strips (bioMe´rieux).
All isolates were ascribed to CC5, SCCmec type IV, ST5
and spa type t002 (paediatric clone), produced PVL and
exhibited resistance to penicillin, cefoxitin and erythro-
mycin (Table 1). Based on their toxin gene profiles, the
isolates were assigned to the first of the three major
variants of the paediatric clone, which harbours sea-N315,
sed, sej and ser (Supplementary Table S1, available in the
online Supplementary Material), discerning them from the
two other variants, which are positive for both sea and
edinA, or edin A only, respectively (Monecke et al., 2011).
The complete microarray data is presented in
Supplementary Table S1.
Discussion
The establishment of CA-MRSA as a cause of infections in
healthy individuals is a matter of great concern. Because of
their high virulence capability, skin infections with PVL-
positive MRSA can rapidly progress to tissue necrosis and
severe necrotizing pneumonia with a high mortality rate,
and are additionally associated with increased risk of
transmission (Boyle-Vavra & Daum, 2007).
Previous studies addressing the epidemiology of CA-
MRSA in Europe indicate that most infections are caused
by a limited number of specific clones with the European
clone (ST80-IVc, t044, PVL+) predominating (Chua et al.,
2011; Otter & French, 2010). In recent years, a changing
trend in the epidemiology has been registered, which is
characterized by a high level of genetic diversity and the
predominance of clones USA300 (ST8-IVa and variants),
the European clone and the Taiwan clone (ST59-IVa and
variants) (Rolo et al., 2012). By contrast, the clone
described in this report is related to the international
HA-MRSA ‘classical’ paediatric clone first reported in a
paediatric hospital in Portugal in 1992 (Oliveira et al.,
2002). This finding is supportive of the notion of
geospatial diversity of currently circulating CA-MRSA
strains.
The prevalence and characteristics of PVL-positive CA-
MRSA in Switzerland is unknown because CA skin
infections are rarely characterized. Overall, the precise
prevalence of CA-MRSA is likely to be higher than
reported because primary manifestation of infection
consisting of the spontaneous appearance of a raised
tender red lesion often leads to the suspicion of a spider
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bite in regions where such occurrences are common, such
as North America and Australia (David & Daum, 2010;
Stryjewski & Chambers, 2008). Most reports of such
lesions have come from the USA and have not been
reported as frequently from other countries. In Switzerland
and other countries where spider bites are rare, these
lesions may be often mistaken by patients for mosquito
bites, as described in this report.
As illustrated by this case, healthy asymptomatic indivi-
duals can serve as reservoirs for this clinically significant
and virulent pathogen, causing repeated transmission
among family members. Although PVL-positive MRSA is
rarely found in asymptomatic carriers (Monecke et al.,
2009), this report suggests that the prevalence may be
higher than hitherto understood and illustrates the need to
test the social environment of an affected patient for
MRSA colonization. The occurrence of PVL genes in
MRSA with ST5 is of concern because of its high capacity
to spread easily and hence its epidemic potential (Mu¨ller-
Premru et al., 2005; Sola et al., 2012)
There is evidence that increased colonization in the
community may be responsible for infiltration of CA-
MRSA into hospital settings, blurring the boundaries
between HA- and CA-MRSA (Stryjewski & Chambers,
2008; Wilson et al., 2010), as exemplified by cases of
transmission of a CA-MRSA from the community to a
neonatal ward and a teaching hospital in Switzerland (Sax
et al., 2006; Valsesia et al., 2010).
Consequently, community-based healthcare providers
such as family doctors play a key role in transmission
prevention. This case highlights the importance of
increased awareness when dealing with recurrent skin
infections affecting either individuals, or individuals
closely associated with each other, as in a family setting.
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